BGM completed the acquisition of YX for $95m.

BGM, a raw material pharmaceutical company, completed the acquisition of YX, an intelligent mobility technology platform, for $95m. "The successful completion of this transaction marks an important milestone in our AI strategy. By integrating YX's technological expertise and industry resources, we will further accelerate the application of AI across key sectors such as insurance and mobility, advancing our core businesses toward an AI Agent-driven model. We believe AI-powered innovation and strategic execution will fuel BGM's long-term growth, delivering sustained value to shareholders, customers, and partners," Mr. Chen Xin, BGM Chief Executive Officer,